Proteinuria with extended VEGF inhibitor therapy in RAS-mutant metastatic colorectal cancer: incidence, interruptions, and exploratory survival analysis.
- DOI
- 10.1007/s00384-026-05210-x
- Published
- 2026 Aug 4
- Container
- International journal of colorectal disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00384-026-05210-x,
title = {Proteinuria with extended VEGF inhibitor therapy in RAS-mutant metastatic colorectal cancer: incidence, interruptions, and exploratory survival analysis.},
author = {Watanabe D and Fujii H and Miura Y and Kani M and Chikaishi W and Tajima JY and Makiyama A and Yamada Y and Ohata K and Hirose C and Iihara H and Kobayashi R and Matsuhashi N and Suzuki A},
year = {2026},
journal = {International journal of colorectal disease},
doi = {10.1007/s00384-026-05210-x},
url = {https://doi.org/10.1007/s00384-026-05210-x}
}RIS
TY - JOUR TI - Proteinuria with extended VEGF inhibitor therapy in RAS-mutant metastatic colorectal cancer: incidence, interruptions, and exploratory survival analysis. AU - Watanabe D AU - Fujii H AU - Miura Y AU - Kani M AU - Chikaishi W AU - Tajima JY AU - Makiyama A AU - Yamada Y AU - Ohata K AU - Hirose C AU - Iihara H AU - Kobayashi R AU - Matsuhashi N AU - Suzuki A PY - 2026 JO - International journal of colorectal disease DO - 10.1007/s00384-026-05210-x UR - https://doi.org/10.1007/s00384-026-05210-x ER -
APA
D, W., H, F., Y, M., M, K., W, C., JY, T., A, M., Y, Y., K, O., C, H., H, I., R, K., N, M., & A, S. (2026). Proteinuria with extended VEGF inhibitor therapy in RAS-mutant metastatic colorectal cancer: incidence, interruptions, and exploratory survival analysis.. International journal of colorectal disease. https://doi.org/10.1007/s00384-026-05210-x
Source records
- pubmed · retrieved 2026-11-10T11:21:34.178Z